{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:40:11Z","timestamp":1778272811697,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00277-016-2883-8","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T22:36:44Z","timestamp":1480372604000},"page":"311-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Predicting risk factors for varicella zoster virus infection and postherpetic neuralgia after hematopoietic cell transplantation using ordered logistic regression analysis"],"prefix":"10.1007","volume":"96","author":[{"given":"Yuko","family":"Kanbayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Horiike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoshi","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Taniwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"2883_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1083-8791(00)70004-8","volume":"6","author":"AM Arvin","year":"2000","unstructured":"Arvin AM (2000) Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 6:219\u2013230","journal-title":"Biol Blood Marrow Transplant"},{"key":"2883_CR2","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.bbmt.2014.06.002","volume":"20","author":"O Blennow","year":"2014","unstructured":"Blennow O, Fjaertoft G, Winiarski J, Ljungman P, Mattsson J, Remberger M (2014) Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis\u2014the incidence remains high. Biol Blood Marrow Transplant 20:1646\u20131649","journal-title":"Biol Blood Marrow Transplant"},{"key":"2883_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","volume":"6","author":"Y Koc","year":"2000","unstructured":"Koc Y, Miller KB, Schenkein DP, Griffith J, Akhtar M, DesJardin J, Snydman DR (2000) Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 6:44\u201349","journal-title":"Biol Blood Marrow Transplant"},{"key":"2883_CR4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.bbmt.2009.03.003","volume":"15","author":"M Onozawa","year":"2009","unstructured":"Onozawa M, Hashino S, Haseyama Y et al (2009) Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients. Biol Blood Marrow Transplant 15:724\u2013729","journal-title":"Biol Blood Marrow Transplant"},{"key":"2883_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/sj.bmt.1702119","volume":"25","author":"TF Leung","year":"2000","unstructured":"Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK, Lee V, Yuen PM (2000) Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant 25:167\u2013172","journal-title":"Bone Marrow Transplant"},{"key":"2883_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1046\/j.1365-2141.2003.04496.x","volume":"122","author":"A Tomonari","year":"2003","unstructured":"Tomonari A, Iseki T, Takahashi S et al (2003) Varicella-zoster virus infection in adult patients after unrelated cord blood transplantation: a single institute experience in Japan. Br J Haematol 122:802\u2013805","journal-title":"Br J Haematol"},{"key":"2883_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/tid.12406","volume":"17","author":"M Mawatari","year":"2015","unstructured":"Mawatari M, Isoda A, Miyazawa Y, Sawamura M, Matsumoto M (2015) A Japanese single-hospital observational trial with a retrospective case-control analysis of varicella zoster virus reactivation after autologous peripheral blood stem cell transplantation. Transpl Infect Dis 17:544\u2013550","journal-title":"Transpl Infect Dis"},{"key":"2883_CR8","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00277-015-2447-3","volume":"94","author":"M Sandherr","year":"2015","unstructured":"Sandherr M, Hentrich M, von Lilienfeld-Toal M, Massenkeil G, Neumann S, Penack O, Biehl L, Cornely OA (2015) Antiviral prophylaxis in patients with solid tumours and haematological malignancies\u2014update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Hematol 94:1441\u20131450","journal-title":"Ann Hematol"},{"key":"2883_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","volume":"157","author":"HJ Forbes","year":"2016","unstructured":"Forbes HJ, Thomas SL, Smeeth L, Clayton T, Farmer R, Bhaskaran K, Langan SM (2016) A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain 157:30\u201354","journal-title":"Pain"},{"key":"2883_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/AJP.0b013e318243ee01","volume":"28","author":"Y Kanbayashi","year":"2012","unstructured":"Kanbayashi Y, Onishi K, Fukazawa K, Okamoto K, Ueno H, Takagi T, Hosokawa T (2012) Predictive factors for postherpetic neuralgia using ordered logistic regression analysis. Clin J Pain 28:712\u2013714","journal-title":"Clin J Pain"},{"key":"2883_CR11","first-page":"1","volume":"57","author":"R Harpaz","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) (2008) Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57:1\u201330","journal-title":"MMWR Recomm Rep"},{"key":"2883_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jinf.2013.06.016","volume":"67","author":"D Weitzman","year":"2013","unstructured":"Weitzman D, Shavit O, Stein M, Cohen R, Chodick G, Shalev V (2013) A population based study of the epidemiology of herpes zoster and its complications. J Infect 67:463\u2013469","journal-title":"J Infect"},{"key":"2883_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12889-015-1753-y","volume":"15","author":"H Bricout","year":"2015","unstructured":"Bricout H, Haugh M, Olatunde O, Prieto RG (2015) Herpes zoster-associated mortality in Europe: a systematic review. BMC Public Health 15:466","journal-title":"BMC Public Health"},{"key":"2883_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1651-2227.2006.00178.x","volume":"96","author":"AK Akobeng","year":"2007","unstructured":"Akobeng AK (2007) Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 96:644\u2013647","journal-title":"Acta Paediatr"},{"key":"2883_CR15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ajh.21152","volume":"83","author":"Y Asano-Mori","year":"2008","unstructured":"Asano-Mori Y, Kanda Y, Oshima K et al (2008) Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Am J Hematol 83:472\u2013476","journal-title":"Am J Hematol"},{"key":"2883_CR16","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","volume":"107","author":"M Boeckh","year":"2006","unstructured":"Boeckh M, Kim HW, Flowers ME, Meyers JD, Bowden RA (2006) Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study. Blood 107:1800\u20131805","journal-title":"Blood"},{"key":"2883_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/sj.bmt.1703214","volume":"28","author":"Y Kanda","year":"2001","unstructured":"Kanda Y, Mineishi S, Saito T et al (2001) Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 28:689\u2013692","journal-title":"Bone Marrow Transplant"},{"key":"2883_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijid.2013.09.020","volume":"19","author":"K Kawamura","year":"2014","unstructured":"Kawamura K, Wada H, Yamasaki R et al (2014) Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. Int J Infect Dis 19:26\u201332","journal-title":"Int J Infect Dis"},{"key":"2883_CR19","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1399-0012.2008.00877.x","volume":"22","author":"DH Kim","year":"2008","unstructured":"Kim DH, Kumar D, Messner HA, Minden M, Gupta V, Kuruvilla J, Chae YS, Sohn SK, Lipton JH (2008) Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for varicella-zoster virus infection after allogeneic peripheral blood stem cell transplantation. Clin Transpl 22:770\u2013779","journal-title":"Clin Transpl"},{"key":"2883_CR20","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","volume":"110","author":"V Erard","year":"2007","unstructured":"Erard V, Guthrie KA, Varley C, Heugel J, Wald A, Flowers ME, Corey L, Boeckh M (2007) One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood 110:3071\u20133077","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2883-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-016-2883-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2883-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:33:13Z","timestamp":1659058393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-016-2883-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2883"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2883-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]},"assertion":[{"value":"7 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.This study was approved by the ethics review boards of Kyoto Prefectural University of Medicine (approval no. ERB-C-594).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}